← All stories
Markets
Gilead yanks out a thorn in its side in major court ruling
A federal appeals court just handed Gilead Sciences (GILD) a legal win that extends into the company's revenue. The decision blocks a group of companies from importing cheaper foreign versions of Gilead's top HIV drug and selling them to Am…
Covered by 1 outlet
All coverage · 1 article